Gadolinium MRI

Superior to contrast CT for evaluating some here-and-gone metastases

MRI enhanced with gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid -the scan referred to as “EOB MRI” - is significantly better than contrast-enhanced CT for assessing colorectal liver metastases that disappear after chemotherapy, according to a study published online March 22 in Radiology.

Photo: Superior to contrast CT for evaluating some here-and-gone metastases
Source: Shutterstock

Min Jung Park, MD, of Yonsei University in Seoul, South Korea, and co-authors describe their work reviewing the cases of 87 patients across eight hospitals who had at least one such metastasis that later disappeared on contrast-enhanced CT scans after chemotherapy and who subsequently underwent surgery for the metastases.

They anonymized the imaging data and radiology reports, then had four radiologists independently review the diagnostic materials.

Defining true absence of tumor as pathologic absence of tumor for resected lesions and no in situ recurrence within one year after surgery for lesions left unresected at each three-month follow-up contrast-enhanced CT, they found:

Among 393 colorectal liver metastases, the positive predictive value for absence of tumor on EOB MR images was significantly higher than that on contrast-enhanced CT scans—78.0 percent for the former vs. 35.2 percent for the latter.

At one year, disappearing liver metastasis on EOB MR imaging left in place without resection had much lower risk of recurrence (6.3 percent; one of 16 lesions) than that on CT imaging (31.4 percent; 11 of 35 lesions).

The positive predictive value for residual tumor on the CT scans was higher than that on EOB MR images, but not to a statistically significant degree.

In their discussion, the authors recommend that, after chemotherapy, colorectal metastasis “should be evaluated with EOB MR imaging rather than contrast-enhanced CT imaging, particularly when considering hepatic resection.”

EOB MR imaging “is more helpful than CT imaging in helping to solve dilemmas of whether disappearing lesions should be included in resections or left in place, especially when hepatic resectability is affected by a particular lesion,” they write.

Source: Dave Pearson, Health Imaging


More on the subject:

Related articles


Article • Photon-counting CT, strain imaging, 4D flow MRI

How new technologies shape the future of cardiovascular radiology

New approaches to cardiovascular radiology are evolving to help clinicians gain an increasingly better insight into heart conditions. Latest developments in cardiovascular radiology include…


News • Smart diagnostic support

Brain imaging: bringing CT up to par with MRI

A new AI method for CT brain imaging may bring the modality to the level of detail usually reserved for MRI scans. This could enhance diagnostic support for conditions such as Alzheimer's disease.


News • Research explores DBGAN method

AI fuses CT and MRI scans for better diagnostics

New research shows how AI can be used to fuse images from clinical X-ray CT and MRI scans to allow a clearer and more clinically useful interpretation of the images.

Related products

Subscribe to Newsletter